Search

Your search keyword '"Salmon, Dominique"' showing total 576 results

Search Constraints

Start Over You searched for: Author "Salmon, Dominique" Remove constraint Author: "Salmon, Dominique"
576 results on '"Salmon, Dominique"'

Search Results

2. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

6. Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies

7. All-cause mortality before and after DAA availability among people living with HIV and HCV: An international comparison between 2010 and 2019

8. Local budesonide therapy in the management of persistent hyposmia in suspected non-severe COVID-19 patients: Results of a randomized controlled trial

9. Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: findings from a multinational cohort between 2010 and 2019

12. Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

13. Inflammation‐, immunothrombosis,‐ and autoimmune‐feedback loops may lead to persistent neutrophil self‐stimulation in long COVID.

15. Acute Hepatitis C

16. Community-acquired bacterial meningitis in adults: in-hospital prognosis, long-term disability and determinants of outcome in a multicentre prospective cohort

17. Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies

18. Long COVID patients continue to experience significant symptoms at 12 months and factors associated with improvement: a prospective cohort study in France (PERSICOR)

20. Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC).

22. VEGF-A plasma levels are associated with impaired DLCO and radiological sequelae in long COVID patients

23. HIV infection and COVID-19: risk factors for severe disease

32. Efficacy of local budesonide therapy in the management of persistent hyposmia in COVID-19 patients without signs of severity: A structured summary of a study protocol for a randomised controlled trial

34. Hepatitis C virus or hepatitis B virus coinfection and lymphoma risk in people living with HIV

36. Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort

38. Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study

40. All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus–coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13–HEPAVIH Cohort

44. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

45. Relationship between serotypes, disease characteristics and 30-day mortality in adults with invasive pneumococcal disease

48. Availability of hepatitis C diagnostics and therapeutics in European and Eurasia countries

49. Risk of severe clinical events after sustained virological response following direct‐acting antiviral therapy in HIV and hepatitis C virus coinfected participants

Catalog

Books, media, physical & digital resources